Clinical Trial Update: Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study [NA]

View source ↗

Summary

Completed pilot study evaluating the Opsens Optowire for fractional flow reserve (FFR) in patients with stable or unstable angina. This update reports the compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia
• Stable Angina Pectoris
• Unstable Angina Pectoris

Drugs mentioned

• Opsens Optowire

Snippet

Sponsor: Laval University | Conditions: Stable Angina, Unstable Angina Pectoris | NA | Status: COMPLETED